89bio, Inc. - Common Stock (ETNB)
9.6000
-0.0400 (-0.41%)
89Bio Inc is a biotechnology company focused on developing innovative therapies for the treatment of liver and metabolic diseases
The company harnesses advanced biological research to create novel solutions aimed at addressing significant unmet medical needs in these areas. With a commitment to improving patient outcomes, 89Bio is dedicated to advancing its product pipeline and clinical programs, leveraging cutting-edge science and technology to deliver new treatment options for patients suffering from liver conditions and associated metabolic disorders.